GSK H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 Philadelphia, PA HQ📍 Collegeville, PA most H-1B filings🌐 gsk.com
Does GSK sponsor H-1B visas and green cards?
Yes. GSK has filed 648 H-1B LCAs and 57 PERM green-card cases with the U.S. Department of Labor between FY2017 and FY2026. In FY2025–2026 GSK filed 128 H-1B LCAs at a median base salary of $127,481, about 5% above the national H-1B median of $121,966 for the same period, and 3 green-card cases were decided.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 65 | $127k |
| FY2025 | 63 | $128k |
| FY2024 | 62 | $146k |
| FY2023 | 62 | $117k |
| FY2022 | 55 | $116k |
| FY2021 | 60 | $117k |
| FY2020 | 75 | $100k |
| FY2019 | 98 | $84k |
| FY2018 | 54 | $94k |
| FY2017 | 54 | $75k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year †
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 1 | $141k |
| FY2025 | 2 | $133k |
| FY2024 | 1 | $108k |
| FY2023 | 7 | $118k |
| FY2022 | 2 | $120k |
| FY2021 | 16 | $111k |
| FY2020 | 15 | $111k |
| FY2019 | 4 | $92k |
| FY2018 | 7 | $108k |
| FY2017 | 2 | $149k |
Green-card route and outcomes
Worker backgrounds · FY2017–2024
Where their green-card (PERM) workers studied & came from
Pay against the local market
GSK’s 10 most-filed occupations and metros. Its median base salary is 104% of the local BLS median for the same work.
| Occupation | Metro | Filings | GSK pay | Local BLS median‡ | vs market |
|---|---|---|---|---|---|
| Medical Scientists | Philadelphia, PA | 79 | $94,447 | $102,140 | 92% |
| Biological Scientists, All Other | Philadelphia, PA | 63 | $98,837 | $87,543 | 113% |
| Statisticians | Philadelphia, PA | 36 | $106,298 | $93,040 | 114% |
| Biochemists and Biophysicists | Philadelphia, PA | 25 | $92,174 | $98,118 | 94% |
| Computer Occupations, All Other | Philadelphia, PA | 22 | $121,978 | $103,604 | 118% |
| Chemists | Philadelphia, PA | 17 | $86,166 | $84,496 | 102% |
| Bioengineers and Biomedical Engineers | Philadelphia, PA | 16 | $113,316 | $84,183 | 135% |
| Medical Scientists | Boston, MA | 14 | $127,489 | $129,230 | 99% |
| Software Developers | Philadelphia, PA | 14 | $115,675 | $106,290 | 109% |
| Medical Scientists | Washington, DC | 13 | $93,852 | $110,671 | 85% |
About GSK
- Legal name
- GSK plc
- Listed
- NYSE: GSK
- Incorporated in
- X0
- Headquarters
- 79 New Oxford Street, London, Wc1a 1dg
- Industry
- Pharma & biotech
- Employees (US, est)
- 12,254 (2024)
- Revenue FY2025
- £32.7B +4% from £31.4B
- Net income FY2025
- £6.3B +113% from £3.0B
- R&D FY2025
- £7.5B (23% of revenue)
Spends 23% of revenue on R&D, against a 73% median across the 122 Pharmaceutical Preparations filers we hold SEC data for.
H-1B sponsors similar to GSK
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Amgen | 3,981 | 745 | $138k | 247 | 46% |
| AbbVie | 2,407 | 562 | $147k | 146 | 77% |
| Bristol Myers Squibb | 2,250 | 441 | $153k | 145 | 83% |
| GSK | 648 | 128 | $127k | 46 | 39% |
| Boehringer Ingelheim | 620 | 120 | $145k | 55 | 73% |
| Amneal Pharmaceuticals | 597 | 99 | $108k | 18 | 55% |
| United Pharma Technologies | 557 | 85 | $102k | 16 | 38% |
